Form 8-K - Current report:
SEC Accession No. 0001739410-25-000093
Filing Date
2025-06-27
Accepted
2025-06-27 16:10:37
Documents
13
Period of Report
2025-06-25
Items
Item 5.02: Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers: Compensatory Arrangements of Certain Officers
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 8-K rlyb-20250625.htm   iXBRL 8-K 32145
2 EX-10.1 rlyb-20250625xex101.htm EX-10.1 122525
  Complete submission text file 0001739410-25-000093.txt   302600

Data Files

Seq Description Document Type Size
3 XBRL TAXONOMY EXTENSION SCHEMA DOCUMENT rlyb-20250625.xsd EX-101.SCH 1773
4 XBRL TAXONOMY EXTENSION LABEL LINKBASE DOCUMENT rlyb-20250625_lab.xml EX-101.LAB 23449
5 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE DOCUMENT rlyb-20250625_pre.xml EX-101.PRE 13575
15 EXTRACTED XBRL INSTANCE DOCUMENT rlyb-20250625_htm.xml XML 2917
Mailing Address 234 CHURCH STREET SUITE 1020 NEW HAVEN CT 06510
Business Address 234 CHURCH STREET SUITE 1020 NEW HAVEN CT 06510 203- 859-3820
Rallybio Corp (Filer) CIK: 0001739410 (see all company filings)

EIN.: 851083789 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-40693 | Film No.: 251086385
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)